Cuidados paliativos para los pacientes terminales internados

1. Hall MJ, Levant S, DeFrances CJ. Trends in inpatient hospital deaths: National Hospital Discharge Survey, 2000- 2010. NCHS Data Brief 2013; 118: 1-8.
2. McCarthy EP, Phillips RS, Zhong Z, Drews RE, Lynn J. Dying with cancer: patients’ function, symptoms, and care preferences as death approaches. J Am Geriatr Soc 2000; 48: Suppl: S110-S121.
3. Puntillo KA, Arai S, Cohen NH, et al. Symptoms experienced by intensive care unit patients at high risk of dying. Crit Care Med 2010; 38: 2155-60.
4. Hui D, Santos RD, Chisholm GB, Bruera E. Symptom expression in the last seven days of life among cancer patients admitted to acute palliative care units. J Pain Symptom Manage 2014 September 19 (Epub ahead of print).
5. Levenson JW, McCarthy EP, Lynn J, Davis RB, Phillips RS. The last six months of life for patients with congestive heart failure. J Am Geriatr Soc 2000; 48: Suppl: S101-S109.
6. Elkington H, White P, Addington-Hall J, Higgs R, Edmonds P. The healthcare needs of chronic obstructive pulmonary disease patients in the last year of life. Palliat Med 2005; 19: 485-91.
7. Institute of Medicine. Dying in America: improving quality and honoring individual preferences near the end of life. Washington, DC: National Academies Press, 2014.
8. Higginson IJ, Evans CJ. What is the evidence that palliative care teams improve outcomes for cancer patients and their families? Cancer J 2010; 16: 423-35.
9. Lupu D. Estimate of current hospice and palliative medicine physician workforce shortage. J Pain Symptom Manage 2010; 40: 899-911.
10. Quill TE, Abernethy AP. Generalist plus specialist palliative care — creating a more sustainable model. N Engl J Med 2013; 368: 1173-5.
11. Truog RD, Campbell ML, Curtis JR, et al. Recommendations for end-of-life care in the intensive care unit: a consensus statement by the American College [corrected] of Critical Care Medicine. Crit Care Med 2008; 36: 953-63.
12. Bernacki RE, Block SD. Communication about serious illness care goals: a review and synthesis of best practices. JAMA Intern Med 2014; 174: 1994-2003.
13. Back AL, Arnold RM, Baile WF, Tulsky JA, Fryer-Edwards K. Approaching difficult communication tasks in oncology. CA Cancer J Clin 2005; 55: 164-77.
14. Tulsky JA. Interventions to enhance communication among patients, providers, and families. J Palliat Med 2005; 8: Suppl 1: S95-S102.
15. Clayton JM, Hancock KM, Butow PN, et al. Clinical practice guidelines for communicating prognosis and end-of-life issues with adults in the advanced stages of a life-limiting illness, and their caregivers. Med J Aust 2007; 186: Suppl 12: S77, S79, S83-108.
16. Blinderman CD, Krakauer EL, Solomon MZ. Time to revise the approach to determining cardiopulmonary resuscitation status. JAMA 2012; 307: 917-8.
17. Wright AA, Zhang B, Ray A, et al. Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA 2008; 300: 1665-73.
18. Mack JW, Weeks JC, Wright AA, Block SD, Prigerson HG. End-of-life discussions, goal attainment, and distress at the end of life: predictors and outcomes of receipt of care consistent with preferences. J Clin Oncol 2010; 28: 1203-8.
19. Kutner JS, Blatchford PJ, Taylor DH Jr, et al. Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial. JAMA Intern Med 2015; 175: 691- 700.
20. Puntillo K, Ley SJ. Appropriately timed analgesics control pain due to chest tube removal. Am J Crit Care 2004; 13: 292-301.
21. Billings JA. Humane terminal extubation reconsidered: the role for preemptive analgesia and sedation. Crit Care Med 2012; 40: 625-30.
22. Teno JM, Clarridge BR, Casey V, et al. Family perspectives on end-of-life care at the last place of care. JAMA 2004; 291: 88- 93.
23. Yuen JK, Reid MC, Fetters MD. Hospital do-not-resuscitate orders: why they have failed and how to fix them. J Gen Intern Med 2011; 26: 791-7.
24. Parsons HA, Shukkoor A, Quan H, et al. Intermittent subcutaneous opioids for the management of cancer pain. J Palliat Med 2008; 11: 1319-24.
25. The SUPPORT Principal Investigators. A controlled trial to improve care for seriously ill hospitalized patients: the study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). JAMA 1995; 274: 1591-8.
26. Jensen MP. The validity and reliability of pain measures in adults with cancer. J Pain 2003; 4: 2-21. 
27. Swarm RA, Abernethy AP, Anghelescu DL, et al. Adult cancer pain. J Natl Compr Canc Netw 2013; 11: 992-1022.
28. Portenoy RK. Continuous intravenous infusion of opioid drugs. Med Clin North Am 1987; 71: 233-41.
29. Portenoy RK, Ahmed E. Principles of opioid use in cancer pain. J Clin Oncol 2014; 32: 1662-70.
30. Breitbart W, Chandler S, Eagel B, et al. An alternative algorithm for dosing transdermal fentanyl for cancer related pain. Oncology (Williston Park) 2000; 14: 695- 705.
31. Caraceni A, Hanks G, Kaasa S, et al. Use of opioid analgesics in the treatment of cancer pain: evidence based recommendations from the EAPC. Lancet Oncol 2012; 13(2): e58-e68.
32. McNicol E, Horowicz-Mehler N, Fisk RA, et al. Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review. J Pain 2003; 4: 231-56.
33. White C, McCann MA, Jackson N. First do no harm…. Terminal restlessness or drug-induced delirium. J Palliat Med 2007; 10: 345-51.
34. Morita T, Tsunoda J, Inoue S, Chihara S. Effects of high dose opioids and sedatives on survival in terminally ill cancer patients. J Pain Symptom Manage 2001; 21: 282-9.
35. Dean M. Opioids in renal failure and dialysis patients. J Pain Symptom Manage 2004;  28: 497-504.
36. Quigley C. Opioid switching to improve pain relief and drug tolerability. Cochrane Database Syst Rev 2004; 3: CD004847.
37. McNicol ED, Midbari A, Eisenberg E. Opioids for neuropathic pain. Cochrane Database Syst Rev 2013; 8: CD006146.
38. Haywood A, Good P, Khan S, et al. Corticosteroids for the management of cancer-related pain in adults. Cochrane Database Syst Rev 2015; 4: CD010756.
39. Gilron I, Bailey JM, Tu D, Holden RR, Weaver DF, Houlden RL. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 2005; 352: 1324-
34. 40. Marciniuk DD, Goodridge D, Hernandez P, et al. Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: a Canadian Thoracic Society clinical practice guideline. Can Respir J 2011; 18: 69-78.
41. Ekström MP, Bornefalk-Hermansson A, Abernethy AP, Currow DC. Safety of benzodiazepines and opioids in very severe  respiratory disease: national prospective study. BMJ 2014; 348: g445.
42. Ben-Aharon I, Gafter-Gvili A, Paul M, Leibovici L, Stemmer SM. Interventions for alleviating cancer-related dyspnea: a systematic review. J Clin Oncol 2008; 26: 2396-404.
43. Mahler DA, O’Donnell DE. Recent advances in dyspnea. Chest 2015; 147: 232-41.
44. Currow DC, Quinn S, Agar M, et al. Double-blind, placebo-controlled, randomized trial of octreotide in malignant bowel obstruction. J Pain Symptom Manage 2015; 49: 814-21.
45. Simon ST, Higginson IJ, Booth S, Harding R, Bausewein C. Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults. Cochrane Database Syst Rev 2010; 1: CD007354.
46. Cranston JM, Crockett A, Currow D. Oxygen therapy for dyspnoea in adults. Cochrane Database Syst Rev 2008; 3: CD004769.
47. Uronis H, McCrory DC, Samsa G, Currow D, Abernethy A. Symptomatic oxygen for non-hypoxaemic chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2011; 6: CD006429.
48. Zhao I, Yates P. Non-pharmacological interventions for breathlessness management in patients with lung cancer: a systematic review. Palliat Med 2008; 22: 693- 701.
49. Galbraith S, Fagan P, Perkins P, Lynch A, Booth S. Does the use of a handheld fan improve chronic dyspnea? A randomized, controlled, crossover trial. J Pain Symptom Manage 2010; 39: 831-8.
50. Dy SM, Apostol CC. Evidence-based approaches to other symptoms in advanced cancer. Cancer J 2010; 16: 507-13.
51. Brody H, Campbell ML, Faber-Langendoen K, Ogle KS. Withdrawing intensive life-sustaining treatment — recommendations for compassionate clinical management. N Engl J Med 1997; 336: 652-7.
52. Blinderman CD. Opioids, iatrogenic harm and disclosure of medical error. J Pain Symptom Manage 2010; 39: 309-13.
53. Bausewein C, Simon ST. Shortness of breath and cough in patients in palliative care. Dtsch Arztebl Int 2013; 110: 563-71.
54. Chung KF. Drugs to suppress cough. Expert Opin Investig Drugs 2005; 14: 19-27.
55. Morice AH, Menon MS, Mulrennan SA, et al. Opiate therapy in chronic cough. Am J Respir Crit Care Med 2007; 175: 312-5.
56. Ryan NM. A review on the efficacy and safety of gabapentin in the treatment of chronic cough. Expert Opin Pharmacother 2015; 16: 135-45.
57. Villa A, Connell CL, Abati S. Diagnosis and management of xerostomia and hyposalivation. Ther Clin Risk Manag 2015; 11: 45-51.
58. Lokker ME, van Zuylen L, van der Rijt CC, van der Heide A. Prevalence, impact, and treatment of death rattle: a systematic review. J Pain Symptom Manage 2014; 47: 105-22.
59. Hui D, Dos Santos R, Chisholm G, Bansal S, Souza Crovador C, Bruera E. Bedside clinical signs associated with impending death in patients with advanced cancer: preliminary findings of a prospective, longitudinal cohort study. Cancer 2015; 121: 960-7.
60. Wee B, Hillier R. Interventions for noisy breathing in patients near to death. Cochrane Database Syst Rev 2008; 1: CD005177.
61. Glare P, Miller J, Nikolova T, Tickoo R. Treating nausea and vomiting in palliative care: a review. Clin Interv Aging 2011; 6: 243-59.
62. Acosta A, Camilleri M. Prokinetics in gastroparesis. Gastroenterol Clin North Am 2015; 44: 97-111.
63. Longford E, Scott A, Fradsham S, et al. Malignant bowel obstruction — a systematic literature review and evaluation of current practice. BMJ Support Palliat Care 2015; 5: 119.
64. Davis MP, Hallerberg G. A systematic review of the treatment of nausea and/or vomiting in cancer unrelated to chemotherapy or radiation. J Pain Symptom Manage 2010; 39: 756-67.
65. Bruera E, Moyano JR, Sala R, et al. Dexamethasone in addition to metoclopramide for chronic nausea in patients with advanced cancer: a randomized controlled trial. J Pain Symptom Manage 2004; 28: 381-8.
66. Tarumi Y, Wilson MP, Szafran O, Spooner GR. Randomized, double-blind, placebo-controlled trial of oral docusate in the management of constipation in hospice patients. J Pain Symptom Manage 2013; 45: 2-13.
67. Thomas J, Karver S, Cooney GA, et al. Methylnaltrexone for opioid-induced constipation in advanced illness. N Engl J Med 2008; 358: 2332-43.
68. Bull J, Wellman CV, Israel RJ, Barrett AC, Paterson C, Forbes WP. Fixed-dose subcutaneous methylnaltrexone in patients with advanced illness and opioid-induced constipation: results of a randomized, placebo-controlled study and open-label extension. J Palliat Med 2015; 18: 593-600.
69. Bruera E, Hui D, Dalal S, et al. Parenteral hydration in patients with advanced cancer: a multicenter, double-blind, placebo- controlled randomized trial. J Clin Oncol 2013; 31: 111-8.
70. Good P, Cavenagh J, Mather M, Ravenscroft P. Medically assisted nutrition for palliative care in adult patients. Cochrane Database Syst Rev 2008; 4: CD006274.
71. Nakagawa S, Toya Y, Okamoto Y, et al. Can anti-infective drugs improve the infection-related symptoms of patients with cancer during the terminal stages of their lives? J Palliat Med 2010; 13: 535-40.
72. Candy B, Jackson KC, Jones L, Leurent B, Tookman A, King M. Drug therapy for delirium in terminally ill adult patients. Cochrane Database Syst Rev 2012; 11: CD004770.
73. Lindqvist O, Lundquist G, Dickman A, et al. Four essential drugs needed for quality care of the dying: a Delphi-study based on international expert consensus opinion. J Palliat Med 2013; 16: 38-43.
74. Savard J, Morin CM. Insomnia in the context of cancer: a review of a neglected problem. J Clin Oncol 2001; 19: 895-908.
75. Holbrook AM, Crowther R, Lotter A, Cheng C, King D. Meta-analysis of benzodiazepine use in the treatment of insomnia. CMAJ 2000; 162: 225-33.
76. Goy ER, Ganzini L. Prevalence and natural history of neuropsychiatric syndromes in veteran hospice patients. J Pain Symptom Manage 2011; 41: 394-401.
77. Bush SH, Leonard MM, Agar M, et al. End-of-life delirium: issues regarding recognition, optimal management, and the role of sedation in the dying phase. J Pain
Symptom Manage 2014; 48: 215-30.
78. Breitbart W, Marotta R, Platt MM, et al. A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry 1996; 153: 231-7.
79. Grassi L, Caraceni A, Mitchell AJ, et al. Management of delirium in palliative care: a review. Curr Psychiatry Rep 2015; 17: 550.
80. Lonergan E, Luxenberg J, Areosa Sastre A. Benzodiazepines for delirium. Cochrane Database Syst Rev 2009; 4: CD006379.
81. Schuckit MA. Recognition and management of withdrawal delirium (delirium tremens). N Engl J Med 2014; 371: 2109-13.
82. Inouye SK, Westendorp RG, Saczynski JS. Delirium in elderly people. Lancet 2014; 383: 911-22.
83. Quill TE, Lo B, Brock DW, Meisel A. Last-resort options for palliative sedation. Ann Intern Med 2009; 151: 421-4.
84. Cherny NI, Radbruch L. European Association for Palliative Care (EAPC) recommended framework for the use of sedation in palliative care. Palliat Med 2009; 23: 581-93.